Table 1 Patients’ baseline characteristics
Index | Eptifibatide + ticagrelor | Ticagrelor | P value |
|---|---|---|---|
N | 152 | 152 | - |
Male sex | 102 (67%) | 117 (77%) | 0.073 |
Age (years) | 63.42 ± 14.56 | 62.62 ± 15.04 | 0.637 |
Body mass index (kg/m2) | 23.61 ± 2.49 | 24.43 ± 4.73 | 0.058 |
Hypertension | 93 (61%) | 93 (61%) | 0.906 |
Diabetes mellitus | 58 (38%) | 67 (44%) | 0.351 |
Atrial fibrillation | 9 (5.9%) | 12 (7.9%) | 0.652 |
Smoking | 70 (46%) | 84 (55%) | 0.168 |
GI history | 30 (1.97%) | 20 (1.32%) | 0.685 |
CVD history | 140 (9.21%) | 130 (8.55%) | 0.84 |
Hemoglobin (g/L) | 130.48 ± 20.96 | 127.29 ± 28.48 | 0.267 |
Triglyceride (mmol/L) | 2.71 ± 1.08 | 2.51 ± 1.09 | 0.103 |
Cholesterol (mmol/L) | 5.18 ± 1.62 | 5.13 ± 1.25 | 0.773 |
LDL-c (mmol/L) | 3.01 ± 1.39 | 2.88 ± 1.24 | 0.425 |
Creatinine (µmol/L) | 91.09 ± 34.45 | 89.06 ± 31.71 | 0.594 |
ALT (U/L) | 33.14 ± 14.83 | 30.21 ± 13.11 | 0.085 |
CK (U/L) | 272.04 ± 261.56 | 240.60 ± 171.17 | 0.217 |
Hs-TnT (µg/L) | 49.10 ± 27.27 | 52.96 ± 25.86 | 0.208 |
Aspirin | 152 (100%) | 152 (100%) | 1 |
Ticagrelor | 152 (100%) | 152 (100%) | 1 |
Statins | 152 (100%) | 152 (100%) | 1 |
Anticoagulation | 9 (5.9%) | 12 (7.9%) | 0.652 |
No. of diseased arteries | 1.92 ± 0.49 | 1.75 ± 0.78 | 0.025* |
No. of stents | 1.19 ± 0.44 | 1.18 ± 0.42 | 0.792 |
TIMI flow grade | 2.88 ± 0.35 | 2.89 ± 0.39 | 1 |
Transradial access | 152 (100%) | 152 (100%) | 1 |
Heparin use | 152 (100%) | 152 (100%) | 1 |